Trials / Conditions / Acute Rejection of Renal Transplant

Acute Rejection of Renal Transplant

9 registered clinical trials studyying Acute Rejection of Renal Transplant — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Unknown	Treating Donors With Intravenous Immunoglobulin to Reduce Donor-Derived Infections NCT05799716	Shanghai Changzheng Hospital	Phase 4
Completed	Donor-derived Cell-free DNA in Kidney Transplant Recipients NCT06476717	Institute for Clinical and Experimental Medicine	—
Recruiting	Dd-cfDNA and Treg in Prediction of Kidney Transplant Acute Rejection NCT05084768	Loma Linda University	—
Active Not Recruiting	Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant NCT04665310	The Methodist Hospital Research Institute	Phase 4
Not Yet Recruiting	European Transplant Registry of Senior Renal Transplant Recipients on Advagraf NCT02558452	Klemens Budde	—
Unknown	Study to Evaluate Safety and Immunologic Biomarker of Rapamune in Patients With Stable Renal Transplant Recipi NCT01592253	Seoul St. Mary's Hospital	N/A
Unknown	The Effects of Pre-transplant Dialysis Modality on Post-transplant Events NCT01513707	Ha Young Oh	—
Completed	Intensified Dosing of Cellcept (Mycophenolate Mofetil) in Kidney Transplantation NCT00943228	Nova Scotia Health Authority	Phase 4
Completed	Reasons for Mycophenolate Mofetil Dose Reduction and Impact on Graft Outcome in Renal Transplant Recipients NCT01496703	Universitaire Ziekenhuizen KU Leuven	—